Holen Sie sich die Stockscreener-App
5.20
1.76%
0.09
Handel nachbörslich:
5.28
0.08
+1.54%
Schlusskurs vom Vortag:
$5.11
Offen:
$5.07
24-Stunden-Volumen:
52,567
Relative Volume:
0.49
Marktkapitalisierung:
$3.99M
Einnahmen:
$9.00M
Nettoeinkommen (Verlust:
$-7.21M
KGV:
-9.4545
EPS:
-0.55
Netto-Cashflow:
$-7.59M
1W Leistung:
+4.42%
1M Leistung:
-1.70%
6M Leistung:
-96.08%
1J Leistung:
-98.32%
1-Tages-Spanne:
$5.07
$5.3485
1-Wochen-Bereich:
$4.88
$5.73
52-Wochen-Spanne:
$4.365
$2,655.00
Applied Dna Sciences Inc Stock (APDN) Company Profile
Firmenname
Applied Dna Sciences Inc
Sektor
Branche
Telefon
631-240-8800
Adresse
50 HEALTH SCIENCES DRIVE, STONY BROOK, NY
Vergleichen Sie APDN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
APDN
Applied Dna Sciences Inc
|
5.20 | 2.58M | 9.00M | -7.21M | -7.59M | -0.55 |
|
TMO
Thermo Fisher Scientific Inc
|
427.62 | 157.79B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
189.91 | 138.02B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
532.00 | 42.36B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
116.19 | 32.08B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
187.38 | 27.28B | 15.50B | 1.33B | 2.16B | 7.34 |
Applied Dna Sciences Inc Stock (APDN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-02-12 | Eingeleitet | ROTH Capital | Buy |
| 2021-01-14 | Bestätigt | H.C. Wainwright | Buy |
| 2020-12-18 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-20 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-11-14 | Bestätigt | Maxim Group | Buy |
| 2016-05-13 | Bestätigt | Maxim Group | Buy |
| 2015-10-08 | Bestätigt | Maxim Group | Buy |
| 2015-05-26 | Eingeleitet | The Benchmark Company | Speculative Buy |
| 2015-02-10 | Bestätigt | Maxim Group | Buy |
| 2015-01-13 | Eingeleitet | Maxim Group | Buy |
Alle ansehen
Applied Dna Sciences Inc Aktie (APDN) Neueste Nachrichten
What analysts say about Applied DNA Sciences Inc. stockGame-changing capital returns - jammulinksnews.com
Is Applied DNA Sciences Inc. a good long term investmentHigh-profit capital plays - jammulinksnews.com
Applied DNA Sciences Inc. Stock Analysis and ForecastSuperior capital gains - jammulinksnews.com
What drives Applied DNA Sciences Inc. stock priceStrong return on investment - Autocar Professional
Is Applied DNA Sciences Inc. stock a good hedge against inflationCapital Doubling Tips - Newser
Applied DNA Regains Compliance with All Nasdaq Continued Listing Requirements - Sentinel-Standard
Why Applied DNA Sciences Inc. stock attracts strong analyst attentionValue Pick Scanner - Newser
How Applied DNA Sciences Inc. stock performs during market volatilityPredictable High Return Trades - Newser
What makes Applied DNA Sciences Inc. stock price move sharplyDouble Your Capital Alerts - Newser
Applied DNA Sciences Regains Nasdaq Compliance - The Globe and Mail
Applied DNA Sciences regains Nasdaq compliance with $1 minimum bid By Investing.com - Investing.com Nigeria
Applied DNA Sciences regains Nasdaq compliance, scheduled hearing cancelled - Investing.com
Applied DNA Sciences regains Nasdaq compliance with $1 minimum bid - Investing.com
Applied DNA Just Cleared Critical $1 Nasdaq Requirement: Delisting Risk Eliminated - Stock Titan
Applied DNA Sciences regains Nasdaq compliance, scheduled hearing cancelled By Investing.com - Investing.com Nigeria
Why Thumzup Media Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Benzinga
Applied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx - Marco Eagle
Applied DNA Sciences Announces Strategic Restructuring - TipRanks
Applied DNA Slashes Workforce by 27% in Major Strategic Shift to $110B DNA Medicine Market - Stock Titan
Dr. James A. Hayward Retires from Applied DNA Sciences - Dentistry Today
Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward - The Tennessean
Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward | APDN Stock News - GuruFocus
Applied DNA Sciences names Judy Murrah as new chairperson and CEO - Investing.com India
Applied DNA Sciences names Judy Murrah as new chairperson and CEO By Investing.com - Investing.com South Africa
APDN Leadership Transition: Judy Murrah Appointed CEO | APDN Sto - GuruFocus
Finanzdaten der Applied Dna Sciences Inc-Aktie (APDN)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.06%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):